Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05838911
Other study ID # BeniSuefU_1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2, 2023
Est. completion date August 13, 2023

Study information

Verified date April 2024
Source Beni-Suef University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Patients with COPD often experience skeletal muscle dysfunction. For those who are unable or unwilling to undertake physical training, neuromuscular electrical stimulation (NMES) may provide an alternative method of exercise training. Objective: To investigate the effects of adding neuromuscular electrical stimulation of gluteus maximus, quadriceps and calf muscles to chest physiotherapy, compared to chest physiotherapy alone, on muscles strength (gluteus max., quadriceps, calf muscles), femoral blood flow physical and pulmonary function in severe COPD Patients.


Description:

Material and methods: This study include a group of 60 patients (30 males and 30 females) diagnosed with severe COPD), their age is ranged 65-75 years, they will be randomly divided into two groups; study group (A) 30 patients and study group (B) 30 patients. Study group (A): The patients in this group will receive the chest physiotherapy program for 20 min each day, for five days a week for three consecutive weeks. Study group (B): The patients in this group will receive the same chest physiotherapy program combined with neuromuscular electrical stimulation of gluteus max., quadriceps, calf muscles, performed for 30 min /day for five days a week for three consecutive weeks. Femoral blood Flow, gluteus maximus, quadriceps and calf muscles strength and pulmonary function (FEV1/FVC) will be measured for both groups pre and post treatment.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date August 13, 2023
Est. primary completion date August 13, 2023
Accepts healthy volunteers No
Gender All
Age group 65 Years to 75 Years
Eligibility Inclusion Criteria: - A diagnosis of COPD with FEV1/FVC <50% predicted as per the GOLD guidelines. - Self-reported dyspnea and/or arm fatigue during at least one activity of daily living that required arm exercise. - Dyspnea and/or physical activity fatigue were self-reported by the Borg Scale. - Before entering in the study, all patients had their pulmonary function optimized with long-acting bronchodilators and corticosteroids. Exclusion Criteria: - • Patients with unstable angina pectoris. - Progressive ventricular dysrhythmia. - Intermittent claudication. - Implanted cardiac pacemakers. - Uncontrolled diabetes mellitus. - Peripheral vascular disease.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES)
The patients in this group were received the same chest physiotherapy program combined with neuromuscular electrical stimulation of gluteus max., quadriceps, and calf muscles performed for 30 min /day for five days a week for three consecutive weeks.
Control Group Chest physical therapy
The patients in this group were received the chest physiotherapy program for 20 min each day, for five days a week for three consecutive weeks

Locations

Country Name City State
Egypt Department of P.T for internal medicine, Faculty of Physical Therapy, South valley university, Qena, Egypt Qina

Sponsors (2)

Lead Sponsor Collaborator
Beni-Suef University South Valley University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Six-minute walking test (Physical function assessment The six-minute walking distance (6MWD) was measured according to a standardized protocol.
Subjects were instructed to walk at their own pace along a 34.5-m corridor from one end to the other, covering as much ground as possible in the allotted time.
Subjects were allowed to stop and rest during the test, but they were instructed to resume walking as soon as they felt able to do
change from baseline to 3 weeks after intervention and 3 days as a follow-up
Primary Pulmonary function test Pulmonary capacity and respiratory muscle functions will be assessed using the CPFS/D USB™ 187 Spirometer (Medical Graphics-MGC, St. Paul, MN, USA) with airflow being measured by a 188 calibrated Pitot tube (PreVent, Pneumotach). The participant completed at least three acceptable maximal forced and slow expiratory maneuvers after 15 min the inhalation of 400 mg of salbutamol 190 via a metered-dose inhaler. Forced vital capacity (FVC, L), forced expiratory volume in one second (FEV1, L), FEV1/ FVC, and inspiratory capacity (IC) will be measured according to American Thoracic Society standards change from baseline to 3 weeks after intervention and 3 days as a follow-up
Primary Muscle strength measurement To determine the maximal muscle strength the Lafayette manual muscle test system (USER MANUAL) (MMT) Model 01163, White Plains, New York (10602) of gluteus maximus, quadriceps and calf muscles will be measured on right lower limb. change from baseline to 3 weeks after intervention and 3 days as a follow-up
Secondary Blood flow velocimetry measurement To evaluate changes in peripheral perfusion. The standard pulsed-wave Doppler velocimetry of the right femoral artery was performed using sonos 2000 echograph (Philips Envisor ) change from baseline to 3 weeks after intervention and 3 days as a follow-up
See also
  Status Clinical Trial Phase
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT02999685 - Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients N/A
Completed NCT03668483 - Relation Between Muscle Strength With Exercise Capacity and Dyspnea in LTx N/A
Completed NCT04880486 - Weight Training With VR in Out-Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT05492149 - Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?
Completed NCT04482634 - Tele-rehabilitation Versus Home Exercise Program in COVID-19 N/A
Completed NCT01246297 - Effect of Pulmonary Rehabilitation in Lung Cancer Survivors N/A
Recruiting NCT05878418 - The Effect of Spinal Orthosis on the Development of Scoliosis and Chest Deformity in Type I Spinal Muscular Atrophy N/A
Completed NCT05063799 - Pulmonary Rehabilitation After Pregnancy in COVID-19 Infection: A Case Report N/A
Completed NCT04722393 - Lung Resection and Pulmonary Rehabilitation N/A
Completed NCT04649918 - Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19
Recruiting NCT05372926 - Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases N/A
Active, not recruiting NCT03740867 - Does Cognitive Status Affect Pulmonary Rehabilitation Gains? N/A
Recruiting NCT04054622 - Patient-ventilator Asychrony During Non-invasive Ventilation When COPD Patients Doing Exercise
Recruiting NCT05315505 - Effectiveness of a Home-based Pulmonary Rehabilitation Program in COPD Patients N/A
Completed NCT05369624 - Exercise Capacity in Non-cystic Fibrosis Bronchiectasis After a Pulmonary Rehabilitation Home-based Program N/A
Active, not recruiting NCT03528447 - The Effect of Pulmonary Rehabilitation on Cognitive Status in Lung Transplantation Candidates N/A
Completed NCT03531138 - Is it Possible to Use the Timed Performance Tests in Lung Transplantation Candidates to Determine the Exercise Capacity? N/A
Completed NCT04279002 - Association of Psycho-social Traits for the Benefit of a First Respiratory Rehabilitation Course - Exploratory Study.
Recruiting NCT04380558 - Prevalence and Consequences of Urinary Incontinence in People With Chronic Pulmonary Diseases Referred for Pulmonary Rehabilitation